MiMedx Group
(NASDAQ:MDXG)
$6.245
0.085[1.38%]
At close: Apr 19
$6.16
-0.0850[-1.36%]
After Hours: 4:20PM EDT
Q1 2024 Earnings in 11 days from now on Tue Apr 30th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
66
0100
Financials Analysis
60
0100

MiMedx Group Stock (NASDAQ:MDXG), Quotes and News Summary

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Open$6.110
Close-
Volume / Avg.376.703K / 779.067K
Day Range6.100 - 6.250
52 Wk Range3.310 - 9.270
Market Cap$917.755M
P/E Ratio14.326
Dividend Yield-
ExchangeNASDAQ
RSI
30
Short Interest
3.55%
Days to Cover5.85

Recent News

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.
Avi Kapoor
Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday
U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.
Lisa Levin
MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities
MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and 
Vandana Singh
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Oct 23
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Mimedx Group Inc
Sector
Health Care
Industry
Biotechnology
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from th...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MDXG
MGNX

FAQ

Q

How do I buy MiMedx Group (MDXG) stock?

A

You can purchase shares of MiMedx Group (NASDAQ: MDXG) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are MiMedx Group's (MDXG) competitors?

A

Other companies in MiMedx Group’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).

Q

What is the target price for MiMedx Group (MDXG) stock?

A

The latest price target for MiMedx Group (NASDAQ: MDXG) was reported by Lake Street on Thursday, March 7, 2024. The analyst firm set a price target for 12.00 expecting MDXG to rise to within 12 months (a possible 94.81% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for MiMedx Group (MDXG)?

A

The stock price for MiMedx Group (NASDAQ: MDXG) is $6.16 last updated April 18, 2024 at 4:20 PM EDT.

Q

Does MiMedx Group (MDXG) pay a dividend?

A

There are no upcoming dividends for MiMedx Group.

Q

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

A

MiMedx Group’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Q

Is MiMedx Group (MDXG) going to split?

A

There is no upcoming split for MiMedx Group.

Q

What sector and industry does MiMedx Group (MDXG) operate in?

A

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch